Scientists identify multiple cell types that may contribute to treatment resistance in prostate cancer


Researchers have characterized prostate cancer cell dynamics at a single-cell resolution across the timespan of the disease—from its beginning to the point of androgen independence, where the tumor no longer responds to hormone deprivation therapy.

Combined epigenetic and immunotherapy for blastic and classical mantle cell lymphoma

Previous article

New look at an ancient disease: Study finds novel treatment targets for gout

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in Innovations